Mutual Fund Research

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

As on Jan-19-2022 change fund
20.46  up-0.01 (-0.05%)

fund objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2018-20192019-20202020-20212021-2022
NAV in Rs (as on 19-Jan-2022)10.149.5417.3520.46
Net Assets(Rs Crores) (as on 19-Jan-2022) 1497.55 1073.47 2213.63 2963.80
Scheme Returns(%)(Absolute)1.40-6.3883.7916.91
B'mark Returns(%)(Absolute)7.46-15.0279.0816.86
Category Rank37/7315/7519/7550/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2021-202217.814.01-1.46NA
2020-202137.1122.3210.75-2.09
2019-2020-4.93-2.399.88-7.74
2018-2019NANA-5.362.63
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...11.53 
Lupin Ltd.10.18 
Cipla Ltd.9.77 
Alkem Laboratories Ltd.7.13 
Dr. Reddy's Laboratories Ltd.5.48 
Ipca Laboratories Ltd.5.47 
Divi's Laboratories Ltd.5.38 
Sanofi India Ltd.4.66 
Indoco Remedies Ltd.3.80 
Torrent Pharmaceuticals Ltd.3.60 

Category

Sector Funds

Launch Date

13-Jul-18

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

2,963.80

portfolio price to book value

5.57

investing style?

Mid Growth

fund manager?

Dharmesh Kakkad,Priyanka Khandelwal

inception date (regular plan)

13-Jul-18

expense ratio (regular plan) %

2.13

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs81.23
Hospital & Healthcare Services9.71
Insurance3.18
Miscellaneous0.70
Finance - Others0.33

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20182,963.8014.0527.62NANA22.53
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,935.1023.2831.28NANA26.92
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,441.8415.8030.81NANA29.70
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015583.2414.3725.9114.84NA9.54
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20045,397.2916.6625.8817.5918.6721.25
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005845.9114.5125.1613.4615.3218.48
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,942.5113.9223.7111.6217.7615.74
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019561.6713.89NANANA28.70
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201974.2610.40NANANA23.62
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021179.31NANANANA0.88
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.